Z
Zhijun Xie
H指数:25
被引数:1,944
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
MX2 and IRF7 are Associated With Disease Activity and Renal Involvement in Systemic Lupus Erythematosus: An Exploratory Study
MX2和IRF7与系统性红斑狼疮的疾病活动性和肾脏受累相关:一项探索性研究
DuoFlow-KG: a dual-modal evidence retrieval framework for high-density LLM-augmented KGQA
DuoFlow-KG:一种高密度LLM增强型KGQA的双模态证据检索框架
Scientific Reports
IF3.9
Sugar-sweetened beverages and the risk of hyperuricemia and gout: a meta-analysis
含糖饮料与高尿酸血症和痛风风险:一项荟萃分析
Genetic and pharmacological targeting of HINT2 promotes OXPHOS to alleviate inflammatory responses and cell necrosis in acute pancreatitis
HINT2的遗传和药理学靶向作用促进氧化磷酸化,以缓解急性胰腺炎中的炎症反应和细胞坏死。
PHARMACOLOGICAL RESEARCH
IF10.5
Network Toxicology and Molecular Docking Analysis of Tetracycline-Induced Acute Pancreatitis: Unveiling Core Mechanisms and Targets
四环素诱导急性胰腺炎的网络毒理学和分子对接分析: 揭示核心机制和靶点
TOXICS
IF4.1
Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis
系统性红斑狼疮患者Th17细胞、Treg细胞及相关细胞因子失衡的meta分析
A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma
用于预测肺腺癌预后和生物标志物的基因组不稳定性相关lncRNA签名
SCIENTIFIC REPORTS
IF3.9
The mechanism of Langchuangding in treatment of systemic lupus erythematosus via modulating TLR7-IRF7-IFNα pathway
狼疮定通过调节tlr7-irf7-ifn α 通路治疗系统性红斑狼疮的机制
HELIYON
IF3.6
Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis
托法替尼联合甲氨蝶呤治疗类风湿关节炎疗效及安全性的系统评价和meta分析
HELIYON
IF3.6

